Coronary Hemodynamics by Coronary Angiography (ESCARGOT)

November 22, 2020 updated by: KangWon National University Hospital

Estimation of Coronary Artery Hemodynamic Profiles Using Cineangiography Technique

Study for developing techniques to evaluate coronary artery hemodynamic profiles by conventional angiography without more dedicated measuring devices.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

* Methods: Compare TIMI frame count, coronary clearance frame count in baseline/hyperemic coronary angiography with FFR, CFR, IMR and derive correlation, receiver-operating characteristic curve to find new tools estimating coronary hemodynamics by conventional angiography only.

A TIMI frame count is measured by counting the angiographic image cine frames during a head of radiocontrast column runs from the entry of left anterior descending artery (LAD) to the distal end.

A coronary clearance frame count is measured by counting the angiographic image cine frames during a tail of radiocontrast column runs from the entry of LAD to the distal end.

Baseline angiography is performed without any stimulation and hyperemic angiography is performed after intracoronary injection of adenosine 300ug or nicorandiol 2mg.

Inclusion criteria

  • Patient who underwent physiologic study using a pressure wire for intermediate coronary lesion after coronary angiography

Exclusion criteria

  • ST elevation myocardial infarction
  • Cardiogenic shock
  • Congestive heart failure with pulmonary edema
  • LVEF < 30%
  • Previous history of coronary revascularization
  • Chronic total occlusion
  • 3 vessel disease
  • Target lesion at distal segments or branches

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Gangwon-do
      • Chuncheon, Gangwon-do, Korea, Republic of, 24289
        • Kangwon National University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion criteria

  • Patient who underwent physiologic study using a pressure wire for intermediate coronary lesion after coronary angiography

Exclusion criteria

  • ST elevation myocardial infarction
  • Cardiogenic shock
  • Congestive heart failure with pulmonary edema
  • LVEF < 30%
  • Previous history of coronary revascularization
  • Chronic total occlusion
  • 3 vessel disease
  • Target lesion at distal segments or branches

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: DIAGNOSTIC
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Hyperemic stimuli
Hyperemic stimuli of coronary flow by adenosine or nicorandil injection
Hyperemic simuli of coronary flow by adenosine or nicorandil injection
Other Names:
  • Hyperemia

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
TIMI frame count
Time Frame: Imediately after the procedure
frame count between the beginning and end of contrast column head
Imediately after the procedure
Coronary Clearance Frame Count
Time Frame: Imediately after the procedure
frame count between the beginning and end of contrast column tail
Imediately after the procedure
Index of microcirculatory resistance
Time Frame: During the procedure
derived from distal coronary pressure by transit time
During the procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fractional flow reserve
Time Frame: During the procedure
measured by pressure wire
During the procedure
Coronary flow reserve
Time Frame: During the procedure
measured by pressure wire by thermodilution technique
During the procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

April 11, 2017

Primary Completion (ACTUAL)

March 25, 2020

Study Completion (ACTUAL)

March 25, 2020

Study Registration Dates

First Submitted

November 4, 2020

First Submitted That Met QC Criteria

November 22, 2020

First Posted (ACTUAL)

November 27, 2020

Study Record Updates

Last Update Posted (ACTUAL)

November 27, 2020

Last Update Submitted That Met QC Criteria

November 22, 2020

Last Verified

November 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Could be shared after necessary discussions

IPD Sharing Time Frame

after publication

IPD Sharing Access Criteria

Investigator who I permitted

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coronary Artery Disease

Clinical Trials on Hyperemic stimuli

3
Subscribe